Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Prelude Therapeutics Incorporated, 3 years.
Prelude Therapeutics Incorporated
Director
ImageneBio Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 21, 2026 | Prelude Therapeutics Incorporated | Open-market purchase | +1,689,189 | $4.44 | $7,499,999 |
| Apr 21, 2026 | Prelude Therapeutics Incorporated | Open-market purchase | +1,126,126 | $4.44 | $4,999,999 |
| Jul 25, 2025 | ImageneBio Inc. | Option exercise | +379 | — | — |
| Jul 25, 2025 | ImageneBio Inc. | Open-market purchase | +83,611 | $29.90 | $2,499,969 |
| Aug 4, 2023 | ImageneBio Inc. | Grant or award | +153,121 | — | — |
| May 22, 2023 | Prelude Therapeutics Incorporated | Open-market purchase | +869,565 | $5.75 | $4,999,999 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.